Optimal First‐line Treatment for Advanced Thymic Carcinoma

Thoracic Cancer - Australia
doi 10.1111/1759-7714.13181
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma

Oncotarget
Oncology
2016English

PCN10 Targeted Therapy (TT) for First Line Treatment of Advanced Renal Cell Carcinoma (RCC): An Indirect Comparison Meta-Analysis (ICMA)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy

Clinical Genitourinary Cancer
OncologyUrology
2015English

Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

First-Line Vascular Endothelial Growth Factor Inhibitors for Advanced Renal Cell Carcinoma and the Impact of New Agents Entering the Treatment Paradigm

BJU International
Urology
2017English

Cost-Effectiveness Analysis of Sunitinib Versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore

International Journal of Technology Assessment in Health Care
Health Policy
2019English

Redefining Treatment Paradigms in First-Line Advanced Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Emerging Treatment Options for Patients With Recurrent Advanced Thymic Epithelial Tumors

OncoTargets and Therapy
OncologyPharmacology
2012English

Pcn190 - Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced or Metastatic Renal Cell Carcinoma in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy